RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease
RAD 1601: Pilot Trial of Frameless Virtual Cone Stereotactic Radiosurgical Thalamotomy for Intractable Tremor and Advanced Functional Connectivity Parcellation of the Thalamus
2 other identifiers
interventional
40
1 country
1
Brief Summary
To determine the efficacy of frameless Virtual Cone Radiosurgical Thalamotomy for medically refractory tremor resulting from either Essential Tremor or Tremor-Dominant Parkinson's Disease with the Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) in patients who are not candidates for deep brain stimulation (DBS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2017
CompletedFirst Posted
Study publicly available on registry
October 10, 2017
CompletedStudy Start
First participant enrolled
December 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedMarch 9, 2026
March 1, 2026
7.8 years
October 4, 2017
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall tremor reduction proportion evaluated by the Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS)
The Fahn-Tolosa-Marin Tremor Rating Scale evaluation will assess the severity of the patient's tremor and measure the impact on their activities of daily living.
From Baseline up to 36 months following completion of radiosurgery
Secondary Outcomes (7)
Number of Participants with treatment-related adverse events
From Baseline up to 36 months following completion of radiosurgery
Changes in resting-state functional MRI (fMRI) and diffusion tensor patterns associated with Radiosurgical thalamotomy
From Baseline up to 36 months following completion of radiosurgery
Mean of Quality of Life Scores measured by SF-36 questionnaire
From Baseline up to 36 months following completion of radiosurgery
Mean of Quality of Life Scores measured by PROMIS Upper Extremity Questionnaire
From Baseline up to 36 months following completion of radiosurgery
Patient Satisfaction Scores
3 Month Follow-Up Visit
- +2 more secondary outcomes
Study Arms (1)
130 Gy Radiation & Unframed Virtual Cone
EXPERIMENTAL130 Gy Virtual Cone Radiosurgery Unframed (Face Mask)
Interventions
The patient will undergo stereotactic radiosurgery. Radiosurgery is a single non-surgical radiation treatment and will be done as an outpatient procedure. High-energy radiation will be delivered to a small, precise area of the patient's brain using a linear accelerator. A face mask (unframed) will be placed over the patient's face to keep their head from moving during the procedure. During the procedure, the study doctor will confirm the exact location that needs to be treated using x-rays and optical imaging cameras. The face mask will hold the patient's head to prevent it from moving and to focus the x-rays and aim them on a small area in the thalamus of the patient's brain. For most patients, the actual time on the radiosurgery treatment machine is 30 to 60 minutes. The face mask will be removed after the treatment.
Eligibility Criteria
You may qualify if:
- Patients with medical refractory essential tremor or tremor-dominant Parkinson's disease that are not candidates for deep brain stimulation (DBS), either by medical/surgical co-morbidities or by choice.
- Patients must have an ECOG status of 0, 1, or 2.
- Patients must be at least 18 years of age.
- All patients must be given written informed consent.
You may not qualify if:
- Patients who have had prior radiosurgery or therapeutic brain radiation therapy.
- Patients with medical contra-indications to MRI imaging (e.g. pacemaker).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center
Birmingham, Alabama, 35249, United States
Related Publications (1)
Middlebrooks EH, Popple RA, Greco E, Okromelidze L, Walker HC, Lakhani DA, Anderson AR, Thomas EM, Deshpande HD, McCullough BA, Stover NP, Sung VW, Nicholas AP, Standaert DG, Yacoubian T, Dean MN, Roper JA, Grewal SS, Holland MT, Bentley JN, Guthrie BL, Bredel M. Connectomic Basis for Tremor Control in Stereotactic Radiosurgical Thalamotomy. AJNR Am J Neuroradiol. 2023 Feb;44(2):157-164. doi: 10.3174/ajnr.A7778. Epub 2023 Jan 26.
PMID: 36702499DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Fiveash, MD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 4, 2017
First Posted
October 10, 2017
Study Start
December 5, 2017
Primary Completion
October 1, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03